• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.

作者信息

Paya C V, Wiesner R H, Hermans P E, Larson-Keller J J, Ilstrup D M, Krom R A, Rettke S, Smith T F

机构信息

Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota 55905.

出版信息

J Hepatol. 1993 Jun;18(2):185-95. doi: 10.1016/s0168-8278(05)80245-4.

DOI:10.1016/s0168-8278(05)80245-4
PMID:8409334
Abstract

Risk factors for cytomegalovirus and severe bacterial infections were studied prospectively by univariate, multivariate and time-dependent Cox model analysis in 79 consecutive liver transplant patients treated with selective bowel decontamination. Cytomegalovirus infection occurred in 39 patients (49%) and was symptomatic in 22 patients. Twenty-six patients (33%) developed at least one of 43 documented severe bacterial infections. In a multivariate analysis of risk factors for all cytomegalovirus infections, the cytomegalovirus seronegative recipient-cytomegalovirus seropositive donor group was the highest risk group (P < 0.001). Using the same analysis for risk factors for symptomatic cytomegalovirus infections, a prolonged prothrombin time (P < 0.005), a diagnosis of acute fulminant hepatitis as the underlying liver disease (P < 0.01) and a cytomegalovirus seronegative patient receiving a liver from a seropositive donor (P < 0.001) were significant. The treatment with OKT3 therapy (P < 0.008) and hepatic artery thrombosis (P < 0.02) were found to be significant risk factors in a time-dependent univariate analysis but were not independent risk factors when multivariate analysis was utilized. Significant risk factors for major bacterial infections (P < 0.03) using univariate analysis included a prolonged anesthesia, anhepatic and surgical times, as well as the transfusion of large amounts of fresh frozen plasma or autologous blood. In a multivariate analysis, only the transfusion of large amounts of fresh frozen plasma (P < 0.04) was a significant independent risk factor. Cytomegalovirus infection was a risk factor for the development of severe bacterial infections (P < 0.03) in a multivariate time-dependent analysis.

摘要

相似文献

1
Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.
J Hepatol. 1993 Jun;18(2):185-95. doi: 10.1016/s0168-8278(05)80245-4.
2
OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation.
J Infect Dis. 1995 Apr;171(4):1014-8. doi: 10.1093/infdis/171.4.1014.
3
Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group.巨细胞病毒感染状态对原位肝移植受者第一年死亡率的影响。波士顿肝移植中心CMVIG研究组。
Ann Intern Med. 1997 Feb 15;126(4):275-9. doi: 10.7326/0003-4819-126-4-199702150-00003.
4
Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.巨细胞病毒感染:巨细胞病毒血清阳性的活体肝移植受者中的发生率和处理:单中心经验。
Liver Transpl. 2012 Dec;18(12):1448-55. doi: 10.1002/lt.23540.
5
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.巨细胞病毒作为原位肝移植受者侵袭性真菌病危险因素的独立作用。波士顿肝移植中心CMVIG研究组。赛美维,MedImmune公司,马里兰州盖瑟斯堡。
Am J Med. 1997 Aug;103(2):106-13. doi: 10.1016/s0002-9343(97)80021-6.
6
Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group.心脏移植后的巨细胞病毒感染及死亡风险因素:一项多机构研究。心脏移植研究数据库组
J Heart Lung Transplant. 1994 May-Jun;13(3):394-404.
7
Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.肝移植中巨细胞病毒免疫球蛋白预防治疗。一项随机、双盲、安慰剂对照试验。
Ann Intern Med. 1993 Nov 15;119(10):984-91. doi: 10.7326/0003-4819-119-10-199311150-00004.
8
A multivariate analysis of risk factors for cytomegalovirus infection in liver-transplant recipients.肝移植受者巨细胞病毒感染危险因素的多变量分析
Gastroenterology. 1990 May;98(5 Pt 1):1326-32. doi: 10.1016/0016-5085(90)90352-2.
9
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
Transplantation. 1995 Mar 27;59(6):851-9.
10
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.接受OKT3治疗的巨细胞病毒抗体血清阳性肾移植受者出现的症状性巨细胞病毒病。
Transplantation. 1992 Jan;53(1):68-72. doi: 10.1097/00007890-199201000-00013.

引用本文的文献

1
[Clinical observation of cidofovir in salvage therapy for cytomegalovirus infection in patients with haploid hematopoietic stem cell transplantation].西多福韦用于单倍体造血干细胞移植患者巨细胞病毒感染挽救治疗的临床观察
Zhonghua Xue Ye Xue Za Zhi. 2020 Apr 14;41(4):326-330. doi: 10.3760/cma.j.issn.0253-2727.2020.04.013.
2
Management of Antimicrobial Agents in Abdominal Organ Transplant Patients in Intensive Care Unit.重症监护病房腹部器官移植患者抗菌药物的管理
Curr Transplant Rep. 2020;7(1):1-11. doi: 10.1007/s40472-020-00268-0. Epub 2020 Jan 24.
3
Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention.
儿童实体器官移植受者的巨细胞病毒感染:聚焦预防
Curr Infect Dis Rep. 2016 Jan;18(2):5. doi: 10.1007/s11908-015-0511-8.
4
Atypical presentation of cytomegalovirus infection in a liver transplant patient.一名肝移植患者巨细胞病毒感染的非典型表现。
J Clin Exp Hepatol. 2011 Dec;1(3):207-9. doi: 10.1016/S0973-6883(11)60236-3. Epub 2012 Jan 2.
5
Bacterial infection after liver transplantation.肝移植后的细菌感染
World J Gastroenterol. 2014 May 28;20(20):6211-20. doi: 10.3748/wjg.v20.i20.6211.
6
Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.人类巨细胞病毒感染中的树突状细胞生物学及其对宿主免疫和病理学的临床后果。
Virulence. 2012 Nov 15;3(7):621-34. doi: 10.4161/viru.22239. Epub 2012 Oct 17.
7
Cytomegalovirus infection-associated fulminant hepatitis in an immunocompetent adult requiring emergency living-donor liver transplantation: report of a case.免疫功能正常的成人巨细胞病毒感染相关性暴发性肝炎需行急诊活体肝移植:病例报告。
Surg Today. 2013 Apr;43(4):424-8. doi: 10.1007/s00595-012-0209-6. Epub 2012 Jul 14.
8
Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.血浆和红细胞输注对肝移植后急性肺损伤和感染风险的影响差异。
Liver Transpl. 2011 Feb;17(2):149-58. doi: 10.1002/lt.22212.
9
Increased serum iron levels and infectious complications after liver transplantation.肝移植后血清铁水平升高与感染并发症。
Clin Infect Dis. 2010 Aug 1;51(3):e16-23. doi: 10.1086/654802.
10
Human cytomegalovirus inhibits cytokine-induced macrophage differentiation.人巨细胞病毒抑制细胞因子诱导的巨噬细胞分化。
J Virol. 2004 Oct;78(19):10378-89. doi: 10.1128/JVI.78.19.10378-10389.2004.